One of the strategies mentioned above for marginalizing motor dysfunction in PD is based on the insertion of additional copies of the normal gene encoding L-amino acid aromatic decarboxylase (AADC), which aims to restore normal biosynthesis of the neurotransmitter dopamine. This evidence concerns the gene DDC and Parkinson disease.